Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma

All ZUMA-7 Investigators and Contributing Kite Members

Research output: Contribution to journalArticlepeer-review

69 Scopus citations

Fingerprint

Dive into the research topics of 'Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences